JOSÉ LUIS PEDRAZ MUÑOZ-rekin lankidetzan egindako argitalpenak (4)

2006

  1. Elimination of piperacillin and tazobactam by renal replacement therapies with AN69 and polysulfone hemofilters: Evaluation of the sieving coefficient

    Blood Purification, Vol. 24, Núm. 4, pp. 347-354

2005

  1. Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 39, Núm. 5, pp. 996-1005

  2. Influence of renal function on the pharmacokinetics of piperacillin/ tazobactam in intensive care unit patients during continuous venovenous hemofiltration

    Journal of Clinical Pharmacology, Vol. 45, Núm. 2, pp. 168-176

  3. Meropenem and continuous renal replacement therapy: In vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients

    Journal of Clinical Pharmacology, Vol. 45, Núm. 11, pp. 1294-1304